Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS | 15 | 11 | +2,29 % | ||
| REVOLUTION MEDICINES | 11 | 5 | +4,53 % | ||
| ALLOGENE THERAPEUTICS | 10 | 6 | -17,05 % | ||
| SPYRE THERAPEUTICS | 10 | 3 | 0,00 % | ||
| IDEAYA BIOSCIENCES | 9 | 3 | -2,83 % | ||
| SANA BIOTECHNOLOGY | 8 | - | +7,49 % | ||
| BIONTECH | 7 | 13 | +1,82 % | ||
| PRAXIS PRECISION MEDICINES | 6 | - | +6,64 % | ||
| LIGAND PHARMACEUTICALS | 5 | 2 | +3,91 % | ||
| BEONE MEDICINES LTD ADR | 4 | 10 | +1,54 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:54 | Truist raises Protagonist Therapeutics stock price target on Icotyde outlook | 3 | Investing.com | ||
| 19:53 | Hebel-Idee | Long-Chance: Statt BioNTech oder Evotec könnte jetzt diese Biotech-Aktie eine Rallye zünden! | 178 | wallstreetONLINE | © Foto: Gorodenkoff / Stock.adobe.comBei der Aktie von Illumina läuft ein Turnaround auf Mehrjahresebene. Nach einer Konsolidierung besteht für Anleger jetzt wieder die Chance zum Einstieg. Willkommen... ► Artikel lesen | |
| 19:36 | Genmab Reports Strong Q1 DARZALEX Sales Near $4 Bln | 129 | AFX News | WASHINGTON (dpa-AFX) - Genmab A/S (GMAB) on Tuesday reported global net trade sales of $3.964 billion for DARZALEX (daratumumab) in the first quarter of 2026, according to company announcements.... ► Artikel lesen | |
| 18:54 | Praxis Precision Medicines stock rating reiterated at Buy by BTIG | 1 | Investing.com | ||
| 18:46 | Travere wins long-awaited approval for kidney disease drug | 2 | BioPharma Dive | ||
| 18:46 | Praxis Precision Medicines: BTIG bekräftigt "Buy"-Rating und Kursziel von 843 US-Dollar | 1 | Investing.com Deutsch | ||
| 18:42 | Jefferies reiterates Praxis Precision Medicines stock rating on FDA review | 1 | Investing.com | ||
| 18:36 | Sanofi: Information concerning the total number of voting rights and shares - March 2026 | 2 | GlobeNewswire (USA) | ||
| 18:34 | Regeneron Boosts Cancer Pipeline Through Telix Collaboration | 5 | Zacks | ||
| 18:34 | Gilead weitet Zugang zu HIV-Präventionsmedikament auf 3 Millionen Menschen aus | 2 | Investing.com Deutsch | ||
| 18:18 | If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today | 5 | Benzinga.com | ||
| 18:18 | Gilead expands HIV prevention drug access to 3 million people | 4 | Investing.com | ||
| 18:02 | Bronstein, Gewirtz & Grossman, LLC: Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm | 163 | Newsfile | New York, New York--(Newsfile Corp. - April 14, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed... ► Artikel lesen | |
| 17:54 | Piper Sandler upgrades Biogen stock rating on acquisition strength | 11 | Investing.com | ||
| 17:46 | Novo teams with OpenAI; Ideaya gets muted response to eye drug data | 18 | BioPharma Dive | ||
| 17:42 | H.C. Wainwright raises Ligand Pharma price target on royalty growth | 1 | Investing.com | ||
| 17:29 | Travere Therapeutics Stock Surges 31% On FDA Approval Of FILSPARI | 1 | RTTNews | ||
| 17:06 | Biogen raised to Overweight at Piper Sandler on Apellis buyout | 2 | Seeking Alpha | ||
| 16:58 | Aktie von Oruka Therapeutics auf neuem Jahreshoch | - | Investing.com Deutsch | ||
| 16:48 | Genmab A/S: Major Shareholder Announcement | 20 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.